List of articles with "Ivonescimab"

Akeso's mRNA Vaccine Trial

Akeso's mRNA Vaccine Trial

Cadonilimab Ivonescimab AK154
Ivonescimab Study Results

Ivonescimab Study Results

China Hong Kong Akeso Ivonescimab HARMONi-A
Ivonescimab's Breakthrough

Ivonescimab's Breakthrough

China Hong Kong TNBC Akeso Ivonescimab
Immunotherapy Breakthrough

Immunotherapy Breakthrough

Hong Kong Akeso Ivonescimab HARMONi-A
Ivonescimab Study Results

Ivonescimab Study Results

China Hong Kong Ivonescimab Chemotherapy HARMONi-6
Summit Therapeutics Fraud Probe

Summit Therapeutics Fraud Probe

USA New York Pomerantz LLP Ivonescimab Summit Therapeutics
Ivonescimab ESMO 2025

Ivonescimab ESMO 2025

China Hong Kong oncology Akeso Ivonescimab
Akeso's ESMO 2025 Highlights

Akeso's ESMO 2025 Highlights

Hong Kong Cadonilimab Ivonescimab Akeso Inc.
Pomerantz Investigation

Pomerantz Investigation

USA New York Pomerantz LLP Ivonescimab Summit Therapeutics
Ivonescimab Efficacy Update

Ivonescimab Efficacy Update

Hong Kong Ivonescimab Chemotherapy HARMONi Trial
Akeso Completes Enrollment

Akeso Completes Enrollment

China Hong Kong Akeso Ivonescimab biliary tract cancer
Akeso 2025 Interim Highlights

Akeso 2025 Interim Highlights

Akeso Cadonilimab Ivonescimab
Akeso IVONES Trial

Akeso IVONES Trial

Hong Kong Akeso Ivonescimab SCLC
Akeso's NSCLC Study Progress

Akeso's NSCLC Study Progress

Hong Kong Akeso Ivonescimab NSCLC
Ivonescimab Approved

Ivonescimab Approved

China Hong Kong Cancer Treatment Akeso Ivonescimab
Ivonescimab Trial Launch

Ivonescimab Trial Launch

Hong Kong pancreatic cancer Akeso Ivonescimab
Akeso's Ivonescimab Trial

Akeso's Ivonescimab Trial

Hong Kong Akeso Ivonescimab Colorectal Cancer
Summit Therapeutics Investor Alert

Summit Therapeutics Investor Alert

United States New York Pomerantz LLP Ivonescimab Summit Therapeutics
Summit Therapeutics Claims

Summit Therapeutics Claims

USA New York Pomerantz LLP Ivonescimab Summit Therapeutics
Ivonescimab Approval

Ivonescimab Approval

China Hong Kong Akeso Ivonescimab NSCLC
Ivonescimab Lung Cancer Breakthrough

Ivonescimab Lung Cancer Breakthrough

China Shanghai Akeso Ivonescimab Lung Cancer
Akeso's 2024 Innovations

Akeso's 2024 Innovations

Hong Kong Akeso Cadonilimab Ivonescimab
Akeso Clinical Trial Results

Akeso Clinical Trial Results

Hong Kong Akeso Ivonescimab Pembrolizumab
Cancer Treatment Advances

Cancer Treatment Advances

Hong Kong Ivonescimab Pfizer Summit Therapeutics
Akeso's New Treatment Trial

Akeso's New Treatment Trial

Hong Kong TNBC Akeso Ivonescimab
Akeso's Trial Enrollment Complete

Akeso's Trial Enrollment Complete

Hong Kong Akeso Ivonescimab Tislelizumab
Akeso's New Drug List Inclusion

Akeso's New Drug List Inclusion

China Hong Kong Akeso Cadonilimab Ivonescimab

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.